A phase 1/2 study of azacitidine, venetoclax and pevonedistat in newly diagnosed secondary AML and in MDS or CMML after failure of hypomethylating agents - Concepedia

Concepedia

Publication | Open Access

A phase 1/2 study of azacitidine, venetoclax and pevonedistat in newly diagnosed secondary AML and in MDS or CMML after failure of hypomethylating agents

DOI Full Paper Access

48

Citations

34

References

2023

Year

Nicholas J. Short, Muharrem Müftüoğlu, Faustine Ong, Lewis Nasr, Walid Macaron, Guillermo Montalban‐Bravo, Yesid Alvarado, Mahesh Basyal, Naval Daver, Courtney D. DiNardo,

Journal of Hematology & Oncology

References

	Year	Citations

Page 1